Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00623519 |
To investigate the global incidence of the endometrial changes in postmenopausal women receiving Anastrozole for the adjuvant treatment of hormone receptors positive breast cancer.
Condition |
---|
Breast Cancer |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole. |
Enrollment: | 165 |
Study Start Date: | June 2004 |
Estimated Study Completion Date: | March 2008 |
Estimated Primary Completion Date: | March 2008 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
1
Women with hormone receptor positive breast cancer under adjuvant treatment with Anastrozole
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Medical Oncology
Inclusion Criteria:
Exclusion Criteria:
Spain | |
Research Site | |
Pontevedra, Spain | |
Research Site | |
Coruña, Spain | |
Research Site | |
Lugo, Spain | |
Research Site | |
Sevilla, Spain | |
Research Site | |
Granada, Spain | |
Research Site | |
Malaga, Spain | |
Research Site | |
La Rioja, Spain | |
Research Site | |
Huelva, Spain | |
Research Site | |
Mallorca, Spain | |
Research Site | |
Ibiza, Spain | |
Research Site | |
Santander, Spain | |
Research Site | |
Jerez, Spain |
Study Director: | Rosana Cajal, MD | AstraZeneca Spain |
Responsible Party: | AstraZeneca Spain ( Rosana Cajal, MD - Medical Director ) |
Study ID Numbers: | AST-ANA-2004-01 |
Study First Received: | February 6, 2008 |
Last Updated: | December 10, 2008 |
ClinicalTrials.gov Identifier: | NCT00623519 |
Health Authority: | Spain: Spanish Agency of Medicines |
Adjuvant postmenopausal breast cancer women |
Anastrozole Skin Diseases Breast Neoplasms Breast Diseases |
Neoplasms Neoplasms by Site Molecular Mechanisms of Pharmacological Action Antineoplastic Agents, Hormonal Antineoplastic Agents |
Therapeutic Uses Enzyme Inhibitors Aromatase Inhibitors Pharmacologic Actions |